Tesamorelin, a manufactured peptide , is attracting increasing interest for its potential uses within the medical field. This novel analogue of GHRH functions by stimulating the release of growth hormone from the pituitary gland . While primarily investigated for the management of lipodystrophy – a disorder characterized by unusual fat placement